| Literature DB >> 30038536 |
Vinícius Ynoe DE Moraes1, Priscila Frantz Ruff1, Carlos Henrique Fernandes1, João Baptista Gomes Dos Santos1, João Carlos Belloti1, Flávio Faloppa1.
Abstract
OBJECTIVE: To assess the applicability of randomized clinical trials and whether certain factors (surgeon experience/journal impact factor) influence their applicability.Entities:
Keywords: Clinical trial; Evidence-based medicine; Reserch
Year: 2018 PMID: 30038536 PMCID: PMC6053970 DOI: 10.1590/1413-785220182603170123
Source DB: PubMed Journal: Acta Ortop Bras ISSN: 1413-7852 Impact factor: 0.513
Summary of studies with low and high chance of applicability, stratified by journal impact factor.
| Journal impact | High chance of applicability | Low chance of applicability |
|---|---|---|
| High | 187 | 173 |
| Low | 157 | 123 |
Chi-square; 1.079; p=0.29.
Interobserver agreement stratified by study and potential applicability: more vs. less experienced.
| Concordance | Kappa | P-value |
|---|---|---|
| Vanni et al | -0.032 | 0.629 |
| Van Heest et al | 0.179 | 0.002* |
| White et al. | -0.009 | 0.852 |
| Zaino et al. | -0.021 | 0.757 |
| Rubin et al. | 0.110 | 0.103 |
| Dundar et al. | -0.114 | 0.087* |
| Orlandi et al. | 0.060 | 0.355 |
| Roh et al. | 0.012 | 0.755 |
| Kolbenschlag et al. | -0.027 | 0.677 |
| Mickelson et al | 0.069 | 0.308 |
| Ekrol et al. | 0.000 | 0.998 |
| McMillan et al. | 0.174 | 0.010* |
| Costa et al. | 0.119 | 0.046* |
| Prosser et al. | 0.043 | 0.525 |
| Vermeulen et al. | 0.018 | 0.721 |
| Vermeulen et al. | 0.012 | 0.815 |
| Walenkamp et al. | 0.059 | 0.376 |
| Buijze et al. | 0.096 | 0.066 |
| Paschos et al. | 0.023 | 0.729 |
| Bentohami et al. | 0.036 | 0.593 |
| Gradl et al. | 0.000 | 1.000 |
| Rocchi et al. | 0.018 | 0.752 |
| Yamazaki et al. | 0.108 | 0.107 |
| Gautam et al. | 0.062 | 0.353 |
| Zhang et al. | 0.110 | 0.092 |
| Lindan et al. | 0.035 | 0.597 |
| Østerås et al. | -0.031 | 0.633 |
| Nam et al. | 0.052 | 0.262 |
| Karlsson et al. | 0.019 | 0.775 |
| Drac et al. | 0.150 | 0.026* |
| Geetha et al. | 0.116 | 0.073 |
| Koman et al. | 0.064 | 0.321 |
Interobserver agreement stratified by study and potential applicability: more vs. less experienced - significant results.
| Concordance | Kappa | P-value |
|---|---|---|
| Van Heest et al. | 0.179 | 0.002 |
| McMillan et al. | 0.174 | 0.010 |
| Costa et al. | 0.119 | 0.046 |
| Buijze et al. | 0.150 | 0.026 |
Number and percentage of “yes” answers, stratified by experience.
| “Yes” answer | More Experienced | Less Experienced | P-value | ||
|---|---|---|---|---|---|
|
|
| ||||
| N | % | N | % | ||
| Vanni et al. | 32 | 80.0% | 34 | 85.0% | 0.556 |
| Van Heest et al. | 25 | 62.5% | 31 | 77.5% | 0.143 |
| White et al. | 18 | 45.0% | 32 | 80.0% | 0.001* |
| Zaino et al. | 21 | 52.5% | 18 | 45.0% | 0.502 |
| Rubin et al. | 28 | 70.0% | 32 | 80.0% | 0.302 |
| Dundar et al. | 27 | 67.5% | 31 | 77.5% | 0.317 |
| Orlandi et al. | 20 | 50.0% | 21 | 52.5% | 0.823 |
| Roh et al. | 33 | 82.5% | 39 | 97.5% | 0.025 |
| Kolbenschlag et al. | 17 | 42.5% | 15 | 37.5% | 0.648 |
| Mickelson et al | 27 | 67.5% | 25 | 62.5% | 0.639 |
| Ekrol et al. | 20 | 50.0% | 26 | 65.0% | 0.175 |
| McMillan et al. | 21 | 52.5% | 16 | 40.0% | 0.262 |
| Costa et al. | 34 | 85.0% | 24 | 60.0% | 0.012* |
| Prosser et al. | 17 | 42.5% | 16 | 40.0% | 0.820 |
| Vermeulen et al. | 14 | 35.0% | 26 | 65.0% | 0.007* |
| Vermeulen et al. | 33 | 82.5% | 37 | 92.5% | 0.176 |
| Walenkamp et al. | 35 | 87.5% | 33 | 82.5% | 0.531 |
| Buijze et al. | 20 | 50.0% | 32 | 80.0% | 0.005* |
| Paschos et al. | 31 | 77.5% | 26 | 65.0% | 0.217 |
| Bentohami et al. | 20 | 50.0% | 23 | 57.5% | 0.501 |
| Gradl et al. | 22 | 55.0% | 11 | 27.5% | 0.012* |
| Rocchi et al. | 32 | 80.0% | 22 | 55.0% | 0.017* |
| Yamazaki et al. | 26 | 65.0% | 21 | 52.5% | 0.256 |
| Gautam et al. | 23 | 57.5% | 21 | 53.8% | 0.744 |
| Zhang et al. | 31 | 77.5% | 35 | 87.5% | 0.239 |
| Lindan et al. | 22 | 59.5% | 28 | 70.0% | 0.333 |
| Østerås et al. | 32 | 80.0% | 28 | 70.0% | 0.302 |
| Nam et al. | 28 | 70.0% | 33 | 91.7% | 0.018* |
| Karlsson et al. | 11 | 27.5% | 16 | 40.0% | 0.237 |
| Drac et al. | 18 | 45.0% | 20 | 50.0% | 0.654 |
| Geetha et al. | 27 | 67.5% | 31 | 77.5% | 0.317 |
| Koman et al. | 14 | 35.0% | 16 | 40.0% | 0.644 |